EditorialCreativeSportsCollectionsVideos
Prices
0Log in

Visual content for professionals.
800M+ images and videos.

Content Hub

  • Current Events
  • Pictures of the Year
  • Sports
  • Editorial
  • Creative
  • Collections
  • Videos

Offers

  • Prices & Packages
  • Promotions
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Content Research
  • Contract Photography
  • API & FTP Push
  • my-picturemaxx
  • Become a Partner

Company

  • About IMAGO
  • Careers
  • News

Help Center

  • FAQ
  • Contact Us
Legal NoticeTerms & ConditionsLicense InformationData PrivacyPrivacy Settings
© 2026 IMAGO
CEPICBAPLABVPA
  3. Coronavirus in the Czech Republic, Pk Clinic in Prague for treatment with the drug Remdesivir

Coronavirus in the Czech Republic, Pk Clinic in Prague for treatment with the drug Remdesivir

Mar 27, 2020

The following photos have been selected for you by the IMAGO picture desk on this topic. For more pictures please use the search function.

Images in this collection

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481601 kru 7 K

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481601 kru 7 K

  • Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481501 kru 3

    Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481501 kru 3

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481101 kru 6

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481101 kru 6

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480601 kru 5

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480601 kru 5

  • Director of the General Teaching Hospital in Prague David Feltl speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480001 kru 4

    Director of the General Teaching Hospital in Prague David Feltl speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480001 kru 4

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270479601 kru 2

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270479601 kru 2

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270470801 kru 1

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270470801 kru 1

Collections